Spero Therapeutics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
38.97 |
5.90 |
1.30 |
32.50 |
38.00 |
106.40 |
| Przychód Δ r/r |
0.00% |
-84.86% |
-77.97% |
2400.00% |
16.92% |
180.00% |
| Przychód (min) |
38.97 |
5.90 |
1.30 |
32.50 |
38.00 |
106.40 |
| Przychód (max) |
38.97 |
5.90 |
1.30 |
32.50 |
38.00 |
106.40 |
| EBITDA (średnia) |
-28.08 |
-4.25 |
-0.94 |
-23.42 |
-27.39 |
-76.68 |
| EBIT (średnia) |
-28.36 |
-4.29 |
-0.95 |
-23.65 |
-27.66 |
-77.44 |
| EBIT % |
-72.78% |
-72.78% |
-72.78% |
-72.78% |
-72.78% |
-72.78% |
| Zysk netto (średni) |
-49.71 |
-62.14 |
25.94 |
-53.50 |
-31.34 |
3.78 |
| Zysk netto % |
-127.58% |
-1053.28% |
1995.25% |
-164.61% |
-82.48% |
3.56% |
| EPS (średnia) |
-0.92 |
-1.15 |
0.48 |
-0.99 |
-0.58 |
0.07 |
| Liczba analityków (Przychody) |
1 |
1 |
1 |
1 |
1 |
1 |
| Liczba analityków (EPS) |
2 |
1 |
1 |
1 |
1 |
1 |
| symbol |
SPRO |
SPRO |
SPRO |
SPRO |
SPRO |
SPRO |